NAV: 22 Oct 2024 | ₹44.26 |
Min. SIP amount | ₹100 |
Rating | 3 |
Fund size | ₹3,094.08Cr |
1Y | 3Y | 5Y | All | |
---|---|---|---|---|
Fund returns | 57.2% | 23.1% | 34.1% | 29.0% |
Category average | 52.0% | 19.2% | 27.8% | NA |
Rank with in category | 6 | 3 | 1 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.68% |
Suven Pharmaceuticals Ltd. | Healthcare | Equity | 9.80% |
Ipca Laboratories Ltd. | Healthcare | Equity | 7.77% |
Lupin Ltd. | Healthcare | Equity | 7.74% |
Cipla Ltd. | Healthcare | Equity | 7.41% |
Alembic Pharmaceuticals Ltd. | Healthcare | Equity | 5.55% |
Globus Medical Inc | Healthcare | Forgn. Eq | 5.21% |
Illumina Inc. (USA) | Healthcare | Forgn. Eq | 4.92% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.33% |
Concord Biotech Ltd. | Healthcare | Equity | 3.84% |
Inclusive of GST
Exit load of 0.50% if redeemed within 1 month.
0.005% (from July 1st, 2020)
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Min. for 1st investment | ₹100 |
Min. for 2nd investment onwards | ₹100 |
Min. for SIP | ₹100 |